- Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
- Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
- Biohaven Announces Pricing of $230 Million Public Offering of Common Shares
- Biohaven Announces Proposed Public Offering of Common Shares
- Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates
- Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
More ▼
Key statistics
On Tuesday, Biohaven Ltd (BHVN:NYQ) closed at 37.94, 143.83% above the 52 week low of 15.56 set on May 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 37.30 |
---|---|
High | 39.84 |
Low | 35.84 |
Bid | 36.01 |
Offer | 39.00 |
Previous close | 37.94 |
Average volume | 1.08m |
---|---|
Shares outstanding | 88.29m |
Free float | 72.29m |
P/E (TTM) | -- |
Market cap | 3.35bn USD |
EPS (TTM) | -6.83 USD |
Data delayed at least 15 minutes, as of May 29 2024 00:00 BST.
More ▼